Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy

Jonathan Z. Li, Brad Chapman, Patrick Charlebois, Oliver Hofmann, Brian Weiner, Alyssa J. Porter, Reshmi Samuel, Saran Vardhanabhuti, Lu Zheng, Joseph Eron, Babafemi Taiwo, Michael C. Zody, Matthew R. Henn, Daniel R. Kuritzkes, Winston Hide, Roy M. Matining, Cara C. Wilson, Baiba I. Berzins, Edward P. Acosta, Barbara BastowPeter S. Kim, Sarah W. Read, Jennifer Janik, Debra S. Meres, Michael M. Lederman, Lori Mong-Kryspin, Karl E. Shaw, Louis G. Zimmerman, Randi Leavitt, Guy De La Rosa, Amy Jennings

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences